Providence tests vaccine against recurrence of breast cancer

It’s been a long-time goal in the fight against cancer: Using the body’s own immune system to fight the disease.

Everett’s Providence Regional Cancer Partnership is one of 13 sites nationally that is testing whether a vaccine, in combination with another medication, is effective in preventing a recurrence in certain types of breast cancer.

They hope to recruit about 50 women to participate in the study. The patients they seek must have low-to-moderate amounts of the HER2 protein present in their cancer.

Currently women with high amounts of HER2 protein are given a drug called Herceptin to try to prevent recurrence. That’s about 25 percent of women diagnosed with breast cancer, said Dr. Jason Lukas, an oncologist at the cancer partnership.

The medical study being conducted in Everett and other sites nationally is to see if this drug, in combination with a vaccine, is effective in preventing a recurrence of breast cancer in women who have low-to-moderate presence of the protein in their tumors.

The vaccine is made in part from the HER2 protein and a drug that stimulates the production of white blood cells.

If the study results show that the combination treatment is effective in preventing breast cancer recurrence, it would be a major step in battling the disease, Lukas said.

The recurrence rate in women who have low-to-moderate amounts of HER2 protein depends on the size of the tumor when they are diagnosed, from a low of 10 percent to as high as 60 percent, he said.

The tests that will be conducted in Everett are the phase 2 trials, or second step tests of the medications. Initial tests involving small groups of women have shown some positive results, dropping the recurrence rate 15 to 20 percent, Lukas said.

“There’s been vaccines tried for other types of solid tumors, but they haven’t yet shown as much potential,” Lukas said. “This is the one where the data seem to be the most compelling.”

The study will document whether women are disease-free 24 months after receiving the treatments.

Some women participating in the study will receive Herception alone. Others will get Herceptin plus the vaccine. Patients will be treated with Herception every three weeks for one year, beginning no later than 12 weeks after completing standard chemotherapy and radiation treatments.

The vaccine treatments will begin with shots every three weeks for a total of six. After that, booster shots are given 12, 18, 24 and 30 months later.

Everett is the only cancer center in Washington participating in the study. Other sites include the M.D. Anderson Cancer Center in Houston, Texas, and the Katzen Cancer Research Center at George Washington University in Washington, D.C.

Lukas said he and another doctor first began exploring the idea of a vaccine to prevent some types of breast cancer recurrence while he was in the Navy. An Army physician they knew also was working to develop the same idea.

Once all three left the military, they worked to launch a national study of the technique, Lukas said.

Vaccines work with the immune system to fight disease. People get cancer because the body’s immune system, for whatever reason, fails to attack it.

The hope is that the vaccine will help Herceptin to work even more effectively, said Marilyn Birchman, clinical research manager at Providence Regional Cancer Partnership.

“It would be nice to have a therapy that’s targeting the breast cancer, with so many less dire effects,” she said. “It’s targeting that cancer cell essentially, and much less toxic than chemotherapy.”

Sharon Salyer: 425-339-3486; salyer@heraldnet.com.

More in Local News

Young woman missing from Mukilteo found safe

She called her parents and told them she was at a museum in Seattle.

Mom and brother turn in suspect in Stanwood robberies

The man is suspected of robbing the same gas station twice, and apologizing to the clerk afterward.

Derrick “Wiz” Crawford, 22, is a suspect in the homicide of his roommate. (Edmonds Police Department)
Roommate suspected in Edmonds killing found hiding in closet

Police had been searching for him for 10 days before locating him at a house in Everett.

Video shows man suspected of attacking a woman in Edmonds

The man allegedly threw her on the ground, then ran away after the she began kicking and screaming.

Navy to put filter in Coupeville’s contaminated water system

Chemicals from firefighting foam was found in the town’s drinking water.

Officials to test sanity of suspect in Everett crime spree

He allegedly tried to rob and clobber a transit worker, then fled and struggled with police.

Katharine Graham, then CEO and chairwoman of the board of The Washington Post Co., looks over a copy of The Daily Herald with Larry Hanson, then The Herald’s publisher, during her visit to Everett on Sept. 20, 1984. The Washington Post Co. owned The Herald from 1978 until 2013. (Herald archives)
Everett’s brush with Katharine Graham, leader of ‘The Post’

Retired Herald publisher Larry Hanson recalls The Washington Post publisher’s visits.

Former Monroe cop loses appeal on sex crimes conviction

Once a highly respected officer, he was found guilty of secretly videotaping his kids’ babysitter.

Families seek to change wrongful death law

A bill would allow or parents or siblings who wish to pursue a suit for an unmarried, childless adult.

Most Read